TEL AVIV, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciS

The U.S. patent applications cover proprietary combinations of NeuroThera's PEA technology with LSD,

This strategic engagement is designed to strengthen NeuroThera's U.S. market position, visibility am

Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-mar

This strategic engagement is designed to strengthen NeuroThera’s U.S. market position, visibility am

This strategic engagement is designed to strengthen NeuroThera's U.S. market position, visibility am

Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 38.0% to $3.45 during Monday's after-market se

 SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroTh

TEL AVIV, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciS

Toronto, Ontario, August 31, 2026 – TheNewswire – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company "

Toronto, Ontario – August 28, 2026 – – TheNewswire - NeuroThera Labs Inc. (TSXV: NTLX) (the " Compan

Toronto, Ontario – August 27, 2026 – TheNewswire - NeuroThera Labs Inc. (TSXV: NTLX) (the " Company

The addition of leading AI researcher further strengthens SciSparc’s scientific and technical founda

The addition of leading AI researcher further strengthens SciSparc's scientific and technical founda

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that its  sub

U.S. publication of a patent application covering the MDMA-N-acylethanolamines combination expands i

SciSparc Invests C$2.7 million and holds approximately 44.6% of NeuroThera’s issued and outstanding

SciSparc Invests C$2.7 million and holds approximately 44.6% of NeuroThera's issued and outstanding

T oronto, Ontario – TheNewswire - August 17, 2026 –  NeuroThera Labs Inc. (the “ Company ” or “ Neur

Toronto, Ontario – August 12, 2026 – TheNewswire - NeuroThera Labs Inc. (the “ Company ” or “ NeuroT

The newly granted Japanese patent covers pharmaceutical compositions and methods comprising propriet

TEL AVIV, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciS

Toronto, Ontario – TheNewswire - A ugust 12 , 2026 – NeuroThera Labs Inc. (TSXV: NTLX) (the " Compan

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroThe

TEL AVIV, Israel, Aug. 05, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciS

Toronto, Ontario – TheNewswire - A ugust 5 , 2026 – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company

SciSparc Ltd. (NASDAQ:SPRC) shares are down more than 20% on Friday.

SciSparc’s subsidiary NeuroThera completes validation of a quantum workflow aimed at enhancing healt

TEL AVIV, Israel, July 31, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciS

Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market sessio

Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's r

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroThe

Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market sess

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that its subs

Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular s

Gainers VYNE Therapeutics (NASDAQ:VYNE) stock increased by 17.9% to $0.79 during Friday's pre-m

Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte

According to the share purchase agreement (the "SPA"), pursuant to which, NeuroThera acquire

U.S. stocks rise, Dow Jones gains 200 points. NASDAQ up 0.73%, S&P 500 up 0.56%. Health care sha

Discover why SciSparc Ltd. (NASDAQ: SPRC) stock is surging today after subsidiary NeuroThera Labs re